These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 30290878)

  • 1. Proarrhythmia and death with antiarrhythmic drugs for atrial fibrillation, and the unfulfilled promise of comparative effectiveness research.
    Reimold FR; Reynolds MR
    Am Heart J; 2018 Nov; 205():128-130. PubMed ID: 30290878
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.
    Lafuente-Lafuente C; Mouly S; Longás-Tejero MA; Mahé I; Bergmann JF
    Arch Intern Med; 2006 Apr; 166(7):719-28. PubMed ID: 16606807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Class I drugs on atrial fibrillation.
    Steinbeck G; Remp T; Hoffmann E
    J Cardiovasc Electrophysiol; 1998 Aug; 9(8 Suppl):S104-8. PubMed ID: 9727684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness of antiarrhythmic drugs on cardiovascular hospitalization and mortality in atrial fibrillation.
    Lakdawalla D; Turakhia MP; Jhaveri M; Mozaffari E; Davis P; Bradley L; Solomon MD
    J Comp Eff Res; 2013 May; 2(3):301-12. PubMed ID: 24236629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drug prevention of recurrence in paroxysmal and chronic atrial fibrillation].
    Hindricks G; Kottkamp H; Willems S; Haverkamp W; Borggrefe M; Breithardt G
    Z Kardiol; 1994; 83 Suppl 5():87-96. PubMed ID: 7846950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New antiarrhythmic drugs for treatment of atrial fibrillation.
    Dobrev D; Nattel S
    Lancet; 2010 Apr; 375(9721):1212-23. PubMed ID: 20334907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex questions command complex analyses: comparative effectiveness of drug treatment strategies in atrial fibrillation.
    Ionescu-Ittu R; Pilote L
    J Comp Eff Res; 2013 Jan; 2(1):1-4. PubMed ID: 24236513
    [No Abstract]   [Full Text] [Related]  

  • 8. Ibutilide: an antiarrhythmic agent for the treatment of atrial fibrillation or flutter.
    Howard PA
    Ann Pharmacother; 1999 Jan; 33(1):38-47. PubMed ID: 9972384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hopes and disappointments with antiarrhythmic drugs.
    Camm AJ
    Int J Cardiol; 2017 Jun; 237():71-74. PubMed ID: 28365182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad complex tachycardia during treatment of atrial fibrillation with a 1c antiarrhythmic drug: ventricular or supraventricular proarrhythmia?
    Wiesfeld AC; Ansink JM; van Veldhuisen DJ; van Gelder IC
    Int J Cardiol; 2006 Feb; 107(1):140-1. PubMed ID: 15990183
    [No Abstract]   [Full Text] [Related]  

  • 11. Benefits and risks of antiarrhythmic drug therapy after DC electrical cardioversion of atrial fibrillation or flutter.
    Crijns HJ; van Gelder IC; Lie KI
    Eur Heart J; 1994 Apr; 15 Suppl A():17-21. PubMed ID: 8070491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antiarrhythmic drugs in atrial fibrillation].
    Brembilla-Perrot B
    Rev Prat; 2002 Jun; 52(12):1317-23. PubMed ID: 12187895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electropharmacological effects of antiarrhythmic drugs on atrial fibrillation termination. Part II: New insights into the electrophysiological mechanisms of atrial fibrillation termination.
    Calò L; Sciarra L; Lamberti F; Loricchio ML; Castro A; Bianconi L; Pandozi C; Gaita F; Santini M
    Ital Heart J; 2003 Jul; 4(7):442-7. PubMed ID: 14558294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New antiarrhythmic agents for atrial fibrillation and atrial flutter.
    Pecini R; Elming H; Pedersen OD; Torp-Pedersen C
    Expert Opin Emerg Drugs; 2005 May; 10(2):311-22. PubMed ID: 15934869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vernakalant: pharmacology electrophysiology, safety and efficacy.
    Naccarelli GV; Wolbrette DL; Samii S; Banchs JE; Penny-Peterson E; Stevenson R; Gonzalez MD
    Drugs Today (Barc); 2008 May; 44(5):325-9. PubMed ID: 18548135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New antiarrhythmic drugs for atrial fibrillation].
    Drici MD
    Ann Cardiol Angeiol (Paris); 2009 Dec; 58 Suppl 1():S61-3. PubMed ID: 20103186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A; Husser D; Cannom DS
    Am J Cardiovasc Drugs; 2005; 5(6):371-8. PubMed ID: 16259525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antiarrhythmic targets in atrial fibrillation.
    Voigt N; Heijman J; Dobrev D
    Future Cardiol; 2015; 11(6):645-54. PubMed ID: 26609872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnesium adjunctive therapy in atrial arrhythmias.
    Ganga HV; Noyes A; White CM; Kluger J
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1308-18. PubMed ID: 23731344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmaceutical pipeline for atrial fibrillation.
    Santangeli P; Di Biase L; Pelargonio G; Burkhardt JD; Natale A
    Ann Med; 2011 Feb; 43(1):13-32. PubMed ID: 21166558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.